We aspire to enable biopharma companies to exceed their goals in developing and delivering life-transforming nucleic-acid therapies, production processes, as well as GMP manufacturing of biopharmaceutical drug substances.
By collaboration with biopharma partners as well as academic institutions, sapientis is establishing a premier ecosystem to enable network effects, scientific progress, and shared learning to speed up the availability of biotechnological solutions for serious diseases within infectious diseases, onco-immunology, and precision medicine in rare diseases, concentrating on pilot projects and delivering products for clinical trial activities.
sapientis is planning to start operating the state-of-the-art cGMP biotechnological pilot plant including development laboratories from Q4 2023 to provide comprehensive GMP development and the complete spectrum of services from discovery to drug substance and drug product development and manufacturing for New Biological Entities (NBEs) worldwide.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Pražákova 1008/69, Brno,south Moravia 63900,czech Republic
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.sapientis.com
- HQ
- Brno, South Moravia
Sapientis Biologics Questions
Sapientis Biologics's website is http://www.sapientis.com
Sapientis Biologics's LinkedIn profile is https://cz.linkedin.com/company/sapientis-biologics
Sapientis Biologics has
2 employees.
View email and phone details for 2
employees at Sapientis Biologics.
Sapientis Biologics's industry is
Biotechnology Research
Sapientis Biologics's top competitors are
Hbs Healthcare Alumni Association,
Radda, S.r.o.,
Mabpro Therapeutics.
Sapientis Biologics's categories are Biotechnology Research
Sapientis Biologics's founding year is 2021
